UNIGE document Scientific Article
previous document  unige:35207  next document
add to browser collection
Title

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research

Authors
Fazio, Nicola
Stupp, Roger
Falk, Stephen
Bernhard, Jürg
Saletti, Piercarlo
Köberle, Dieter
Borner, Markus M
show hidden authors show all authors [1 - 16]
Published in Journal of Clinical Oncology. 2007, vol. 25, no. 22, p. 3217-23
Abstract This randomized phase II trial evaluated two docetaxel-based regimens to see which would be most promising according to overall response rate (ORR) for comparison in a phase III trial with epirubicin-cisplatin-fluorouracil (ECF) as first-line advanced gastric cancer therapy.
Keywords Adenocarcinoma/drug therapy/pathologyAdultAgedAntineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic useCisplatin/administration & dosageEpirubicin/administration & dosageFemaleFluorouracil/administration & dosageHumansMaleMiddle AgedQuality of LifeStomach Neoplasms/drug therapy/pathologyTaxoids/administration & dosageTreatment Outcome
Identifiers
PMID: 17664469
Full text
Article (Published version) (97 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe Roth Arnaud (oncologie) (285)
Citation
(ISO format)
ROTH, Arnaud et al. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. In: Journal of Clinical Oncology, 2007, vol. 25, n° 22, p. 3217-23. https://archive-ouverte.unige.ch/unige:35207

281 hits

0 download

Update

Deposited on : 2014-04-01

Export document
Format :
Citation style :